BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
213 hedge funds and large institutions have $3.24B invested in Blueprint Medicines in 2020 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 98 increasing their positions, 55 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
213
Holders Change
-14
Holders Change %
-6.17%
% of All Funds
4.71%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
36
Increased
98
Reduced
55
Closed
48
Calls
$36.3M
Puts
$29.3M
Net Calls
+$7.04M
Net Calls Change
+$20.3M
Top Buyers
| 1 |
HM
1
HealthCor Management
New York
|
$74.9M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$56.7M |
| 3 |
3
Alkeon Capital Management
New York
|
$65.1M |
| 4 |
4
Victory Capital Management
San Antonio,
Texas
|
$77.7M |
| 5 |
CC
5
Casdin Capital
New York
|
$90.6M |
